Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oreste Livi

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
European Journal of Medicinal Chemistry|October 17, 2003
New N6- or N(9)-hydroxyalkyl substituted 8-azaadenines or adenines as effective A1 adenosine receptor ligandsGiuliana Biagi, Irene Giorgi, Michele Leonardi, et al.
Bioorganic & Medicinal Chemistry|November 26, 2008
QSAR studies on BK channel activatorsAlessio Coi, Francesca Lidia Fiamingo, Oreste Livi, et al.
European Journal of Medicinal Chemistry|June 9, 2004
Synthesis and biological activity of novel substituted benzanilides as potassium channel activators. VGiuliana Biagi, Irene Giorgi, Oreste Livi, et al.
European Journal of Medicinal Chemistry|October 13, 2006
Structural modifications of benzanilide derivatives, effective potassium channel openers. XVincenzo Calderone, Alessio Coi, Francesca Lidia Fiamingo, et al.
Farmaco (Societa Chimica Italiana : 1989)|May 7, 2002
Erythro- and threo-2-hydroxynonyl substituted 2-phenyladenines and 2-phenyl-8-azaadenines: ligands for A1 adenosine receptors and adenosine deaminaseGiuliana Biagi, Irene Giorgi, Oreste Livi, et al.
European Journal of Medicinal Chemistry|November 30, 2007
N6-1,3-diphenylurea derivatives of 2-phenyl-9-benzyladenines and 8-azaadenines: synthesis and biological evaluation as allosteric modulators of A2A adenosine receptorsIrene Giorgi, Giuliana Biagi, Anna Maria Bianucci, et al.
European Journal of Medicinal Chemistry|October 10, 2006
Synthesis, biological activity and molecular modelling of new trisubstituted 8-azaadenines with high affinity for A1 adenosine receptorsIrene Giorgi, Anna Maria Bianucci, Giuliana Biagi, et al.
Bioorganic & Medicinal Chemistry|May 24, 2005
2,9-disubstituted-N6-(arylcarbamoyl)-8-azaadenines as new selective A3 adenosine receptor antagonists: synthesis, biochemical and molecular modelling studiesGiuliana Biagi, Anna Maria Bianucci, Alessio Coi, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
European Journal of Medicinal Chemistry|October 17, 2003
New N6- or N(9)-hydroxyalkyl substituted 8-azaadenines or adenines as effective A1 adenosine receptor ligandsGiuliana Biagi, Irene Giorgi, Michele Leonardi, et al.
Bioorganic & Medicinal Chemistry|November 26, 2008
QSAR studies on BK channel activatorsAlessio Coi, Francesca Lidia Fiamingo, Oreste Livi, et al.
European Journal of Medicinal Chemistry|June 9, 2004
Synthesis and biological activity of novel substituted benzanilides as potassium channel activators. VGiuliana Biagi, Irene Giorgi, Oreste Livi, et al.
European Journal of Medicinal Chemistry|October 13, 2006
Structural modifications of benzanilide derivatives, effective potassium channel openers. XVincenzo Calderone, Alessio Coi, Francesca Lidia Fiamingo, et al.
Farmaco (Societa Chimica Italiana : 1989)|May 7, 2002
Erythro- and threo-2-hydroxynonyl substituted 2-phenyladenines and 2-phenyl-8-azaadenines: ligands for A1 adenosine receptors and adenosine deaminaseGiuliana Biagi, Irene Giorgi, Oreste Livi, et al.
European Journal of Medicinal Chemistry|November 30, 2007
N6-1,3-diphenylurea derivatives of 2-phenyl-9-benzyladenines and 8-azaadenines: synthesis and biological evaluation as allosteric modulators of A2A adenosine receptorsIrene Giorgi, Giuliana Biagi, Anna Maria Bianucci, et al.
European Journal of Medicinal Chemistry|October 10, 2006
Synthesis, biological activity and molecular modelling of new trisubstituted 8-azaadenines with high affinity for A1 adenosine receptorsIrene Giorgi, Anna Maria Bianucci, Giuliana Biagi, et al.
Bioorganic & Medicinal Chemistry|May 24, 2005
2,9-disubstituted-N6-(arylcarbamoyl)-8-azaadenines as new selective A3 adenosine receptor antagonists: synthesis, biochemical and molecular modelling studiesGiuliana Biagi, Anna Maria Bianucci, Alessio Coi, et al.
Pageof 2